Jury to Decide: Were Shkreli’s Gambles to Save His Drug Company Criminal?
Evan Greebel, a lawyer who worked for Mr. Shkreli, emailed him about the shares: “I’m listing
everyone’s addresses as c/o msmb…does that work for you?” Mr. Shkreli replied: “no!
“If Retrophin doesn’t raise $1m in the near future, I think you know what the result will be.”
Then Mr. Shkreli called Mr. Pierotti, “screaming and yelling,” Mr. Pierotti testified.
“I have been extremely stressed about Retrophin; the declining stock price is particularly alarming,” Mr. Shkreli wrote.
Suddenly, in September 2012, Mr. Shkreli emailed investors
that he was shutting down MSMB Capital and MSMB Healthcare to focus on Retrophin and that they could cash out.
The price of the shell company Retrophin was buying had suddenly gone up, Mr. Shkreli told an investor.
